Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Safe Orthopaedics
  6. News
  7. Summary
    ALSAF   FR0013467123

SAFE ORTHOPAEDICS

(ALSAF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Safe Orthopaedics :áFirst Surgeries with SteriSpine™ CC & LC Completed in Japan

01/23/2020 | 12:14pm EDT

Regulatory News:

SAFE ORTHOPAEDICS (FR0013467123 – ALSAF), a company marketing innovative ready-to-use technologies (single-use implants and instruments) for spinal diseases, delivering the safest treatment of spinal fractures, announces that ten surgeries have been completed in Japan since SteriSpine CC (Cervical cages) & LC (Lumbar cages) have been approved in October, 2019.

The partnership agreement with KiSCO Co., Ltd. (KiSCO) for exclusive commercialization and distribution rights for Japan was signed in June 2018. SteriSpine™ CC & LC were launched in Japan in November 2019.

Dr. Murakoshi at Nagayama Hospital, said: "SteriSpine is a product that has the possibility of both time-saving and cost-saving for surgical teams as it eliminates the need for cleaning and sterilization processes as well as reducing the burden of increased expenses caused by surgical site infections. In particular, the ability to reduce staff hours is very beneficial with new approaches. Our hospital is starting to use SteriSpine CC which is now a solution held in high regard by our surgical staff."

"After the success of the SteriSpine PS launch in Japan, we are proud to announce the first results from the SteriSpine CC & LC commercial launch with our partner, KiSCO. This includes ten surgical interventions with positive feedbacks from surgeons, as expressed by Dr. Murakoshi. This is an evidence that only strengthens our ambitions for Japan, the third largest global market for spinal implant with an estimated value of €400 million," said Pierre Dumouchel, Chairman and Chief Executive Officer of Safe Orthopaedics. "We would also like to acknowledge the professionalism of our partner, KiSCO and the benefits this type of partnership brings. It is this type of market access that we want to access the largest countries as US and China."

About Safe Orthopaedics

Founded in 2010, Safe Orthopaedics is a French medical technology company, pionner of design and marketing innovative ready-to-use technologies (single-use implants and instruments) for spinal diseases, delivering the safest treatment of spinal fractures. The technologies include sterile implants and ready-to-use instruments available to the surgeon at any time and anywhere, enable minimally invasive approaches, reduce risks of cross contamination and infection in the interest of the patient. Protected by 17 patent families, the SteriSpineTM Kits are CE marked, FDA and CFDA approved. Safe Orthopaedics located its headquarter close to Paris (95610 Eragny-Sur-Oise - France), created a substidiary in UK, Germany and in US, employing around 50 employees for a total sales of 4.7M€ in 2019.

For more information: www.SafeOrthopaedics.com


ę Business Wire 2020
All news about SAFE ORTHOPAEDICS
07/09SAFE ORTHOPAEDICS : announces its revenues for the first half of 2021 - Corrective documen..
GL
07/08GLOBAL MARKETS LIVE : Microsoft, Deliveroo, Didi, Biogen, Tesla...
07/07SAFE ORTHOPAEDICS : announces its revenues for the first half of 2021
GL
07/07Safe Orthopaedics Announces Revenue Results for the Second Quarter and Six Months Ended..
CI
06/18SAFE ORTHOPAEDICS : Minutes of the annual ordinary and extraordinary general meeting of ju..
GL
06/18SAFE ORTHOPAEDICS : Proxy Statments
CO
05/31SAFE ORTHOPAEDICS : Wins Patent Infringement Case Against Neo Medical In France
MT
05/31SAFE ORTHOPAEDICS : announces the Paris Court of Justice judgment in its favor in the infr..
PU
05/31SAFE ORTHOPAEDICS : announces the Paris Court of Justice judgment in its favor in the infr..
GL
05/27SAFE ORTHOPAEDICS : Secure CE Mark For New Hickory Screw
MT
More news
Financials
Sales 2021 5,51 M 6,44 M 6,44 M
Net income 2021 - - -
Net Debt 2021 7,30 M 8,53 M 8,53 M
P/E ratio 2021 -
Yield 2021 -
Capitalization 21,0 M 24,5 M 24,5 M
EV / Sales 2021 5,13x
EV / Sales 2022 4,24x
Nbr of Employees 140
Free-Float 98,6%
Chart SAFE ORTHOPAEDICS
Duration : Period :
Safe Orthopaedics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SAFE ORTHOPAEDICS
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,43 €
Average target price 0,65 €
Spread / Average Target 49,7%
Managers and Directors
Pierre Dumouchel Chairman & Chief Executive Officer
Franšois-Henri Reynaud Director, Chief Financial & Administrative Officer
Thomas Droulout Chief Technology Officer & Director
IsmaŰl Nujurally Independent Director
Philippe Chŕne Independent Director
Sector and Competitors